Staphylococcal Skin Infections

S. aureus uses surface adhesins like clumping factor B and SasG to bind to host proteins loricrin and cytokeratin on skin cells. This attachment allows bacteria to persist locally and initiate infection when the skin barrier is breached. Protein A further impairs immunity by binding immunoglobulin Fc regions, reducing opsonization and enabling colonization.

Coagulase is a virulence factor that activates prothrombin, converting fibrinogen to fibrin and forming a protective clot around bacterial colonies. This fibrin shield localizes the infection and shields bacteria from phagocytosis, allowing persistent infection and tissue damage to occur.

Leukocidins are toxins produced by S. aureus that lyse neutrophils and other white blood cells, reducing immune clearance of the bacteria. By destroying these key immune cells, leukocidins enable persistent infection and allow the bacteria to cause progressive tissue injury.

Folliculitis causes erythematous, pus-filled papules around hair follicles. Furuncles are deeper, painful nodules containing necrotic tissue and pus. Carbuncles form when multiple furuncles coalesce, extending into the deeper dermis and subcutaneous tissue, often accompanied by fever or malaise.

Staphylococcal scalded skin syndrome (SSSS) is caused by exfoliative toxins A and B, serine proteases that cleave desmoglein-1, disrupting keratinocyte adhesion in the stratum granulosum. This produces widespread erythema, fragile blisters, and epidermal peeling. SSSS primarily affects neonates and young children but may occur in immunocompromised adults.

S. aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals as part of normal microbiota. It only becomes pathogenic when the skin barrier is breached, allowing it to shift from commensal to opportunistic pathogen and deploy virulence factors.

Methicillin-resistant S. aureus (MRSA) strains pose additional therapeutic challenges due to antibiotic resistance. Combined with potent adhesins, immune evasion molecules, and tissue-damaging toxins, MRSA makes S. aureus one of the most clinically important pathogens in dermatology, capable of causing both localized and systemic disease.